Abstract:Objective To investigate the therapeutic effects of mesenchymal stem cells (MSC) on rat fulminant hepatic failure (FHF). Methods The rat MSC were separated and purified by adherent culture of whole bone marrow cells. The rat FHF models were established by CCl4 intragastric administration.The rats were divided into experimental group (n=20) and model control group (n=20).And the same dose of saline was administered to rats as normal controls (n=8).Dosage of 1.0 × 106 4',6-diamidino-2-phenylindole (DAPI) labeled MSC were transplanted into rats in experimental group and normal control group through caudal veins,and the same dose of saline was given intravenously in model control group.Part of rats in each group were sacrificed after 7 days and 14 days of injection to evaluate the general condition,survival rate,liver function,tumor necrosis factor (TNF)-α level,liver pathology and MSC homing to the liver between experimental group and model control group.Normal distribution data were compared by independent-sample t test and nonnormal distribution data were analyzed by non-parameter test.Results After 3 days of injection,the general condition of experimental group were better than the model control group. After 7 days of injection,there were 15 and 8 survival rats,the survival rates were statistically different between experimental group and model control group (x2 =4.122,P＜0.05).After 7 days and 14 days of injection,the liver function and TNF-α levels were statistically different between experimental group and model control group (both P ＜0.05),and liver pathology improvement in experimental group was more significant than model control group.DAPI labeled cells increased after transplantation in experimental group, while few DAPI labeled cells were observed in normal control group.Conclusions MSC can home to liver of FHF rats after MSC allogeneic transplantation through caudal veins,which can improve liver immunity and liver tissue necroinflammation,and facilitate recovery of liver function.Therefore,it is demonstrated that MSC transplantation has obvious therapeutic effect on rat FHF.

Protective Effects of Mesenchymal Stem Cells with CXCR4 Up-Regulation in a Rat Renal Transplantation Model.

The preliminarily investigation of therapeutic effects of mesenchymai stem cells on rat fulminant hepatic failure

CXCR4-transduced Mesenchymal Stem Cells Protect Mice Against Graft-Versus-host Disease.

Mesenchymal stem cells overexpressing C-X-C chemokine receptor type 4 improve early liver regeneration of small-for-size liver grafts.

Co-transplantation of Hematopoietic Stem Cells and Cxcr4 Gene-Transduced Mesenchymal Stem Cells Promotes Hematopoiesis

Overexpression of the Mesenchymal Stem Cell Cxcr4 Gene in Irradiated Mice Increases the Homing Capacity of These Cells

Establishment of Mouse Mesenchymal Stem Cells Overexpressing CXCR4 Gene and Evaluation of Their Functions

CXCR4-overexpressing bone marrow-derived mesenchymal stem cells improve repair of acute kidney injury

Transfection With Cxcr4 Potentiates Homing Of Mesenchymal Stem Cells In Vitro And Therapy Of Diabetic Retinopathy In Vivo

Mesenchymal Stem Cells Ameliorate Hepatic Ischemia/Reperfusion Injury via Inhibition of Neutrophil Recruitment

Mesenchymal stem cells infusion prevents acute cellular rejection in rat kidney transplantation

Targeted Migration of Mesenchymal Stem Cells Modified with CXCR4 to Acute Failing Liver Improves Liver Regeneration.

Transforming Growth Factor-Β1 Promotes Homing of Bone Marrow Mesenchymal Stem Cells in Renal Ischemia-Reperfusion Injury.

Arterially Transplanted Mesenchymal Stem Cells in a Mouse Reversible Unilateral Ureteral Obstruction Model: in Vivo Bioluminescence Imaging and Effects on Renal Fibrosis

Transforming Growth Factor-Β1 in the Microenvironment of Ischemia Reperfusion-Injured Kidney Enhances the Chemotaxis of Mesenchymal Stem Cells to Stromal Cell-Derived Factor-1 Through Upregulation of Surface Chemokine (C-X-C Motif) Receptor 4

The Role of SDF-1-CXCR4/CXCR7 Axis in the Therapeutic Effects of Hypoxia-Preconditioned Mesenchymal Stem Cells for Renal Ischemia/Reperfusion Injury

Maximum Efficacy of Mesenchymal Stem Cells in Rat Model of Renal Ischemia-Reperfusion Injury: Renal Artery Administration with Optimal Numbers.

The Role of CD44-hyaluronic Acid Interaction in Exogenous Mesenchymal Stem Cells Homing to Rat Remnant Kidney.

Effects of mesenchymal stem cells transplanted at different time points in a rat remnant kidney model.

Optimal Temporal Delivery of Bone Marrow Mesenchymal Stem Cells in Rats with Myocardial Infarction.

Protective Effect of MSCs by Distinct Administration Time on Renal Ischemia-Reperfusion Injury in Rats